Serotonin and its receptors in the human CNS with new findings - A mini review

Current Medicinal Chemistry

Volumn 18, Issue 34, 2011, Pages 5281-5288

  Hung, A S M ^a   Tsui, T Y M ^a   Lam, J C Y ^a   Wai, M S M ^a   Chan, W M ^a   Yew, D T ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

5HT 2A; 5HT 1A; Animal; Brainstem; Cerebellum; Cortex; Human; Serotonin; Serotonin receptors; Seven subtypes

Indexed keywords

4 AMINOBUTYRIC ACID; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1B AGONIST; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

CENTRAL NERVOUS SYSTEM; DEPRESSION; DEVELOPMENTAL STABILITY; EMOTIONAL DISORDER; HUMAN; NONHUMAN; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC NERVE CELL;

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; HUMANS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 82255195365     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711798184253     Document Type: Review

References (98)

1. Baumgarten, H. G.; Lachenmayer, L. Anatomical Features and physiological properties of central serotonin neurons. Pharmacopsychiatry, 1985, 18, 180-287.
2. Hoyer, D.; Martin, G. Classification and nomenclature of 5-HT receptors: a comment on current issues. Behav. Brain Res., 1996, 73, 263-8. (Pubitemid 26008793)
3. Barners, N.; Sharp, T. A review of central 5-HT receptors and their function. Neuropharmacology, 1999, 38, 1083-1152. (Pubitemid 29292403)
4. Hoyer, D.; Hannon, P.; Martin, G. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav., 2002, 71, 533-54. (Pubitemid 34219205)
5. 2 receptor is encoded by a multiple intron-exon gene. Brain Res Mol Brain Res., 1992, 14, 20-6.
6. 1A receptor genes. Eur. J. Pharmacol., 1992, 227, 153-62.
7. Yu, L.; Nguyen, H.; Le, H., et al. The mouse 5-HT1C receptor contains eight hydrophobic domains and is X-linked. Brain Res. Mol. Brain Res., 1991, 11, 143-9.
8. Hoyer, D.; Martin, G. 5-HT receptor-classification and nomenclature: towards harmonization with the human genome. Neuropharmacology, 1997, 36, 419-28. (Pubitemid 27272086)
9. Blondel, O.; Gastineau, M.; Dahmoune, Y.; Langlois, M.; Fischmeister, R. Cloning, expression and pharmacology of four human 5-hydroxy tryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus. J. Neurochem., 1998, 70, 2252-61. (Pubitemid 28252350)
10. Madsen, K.; Haahr, M. T.; Marne, L.; Keller, S. H.; Baaré, W. F.; Svarer, C.; Hasselbalch, S. G.; Knudsen, G. M. Age and sex effects on 5-HT (4) receptors in the human brain: a [(11) C]SB207145 PET study. J. Cereb. Blood Flow Metab., [Online] 2011, 6, 1475-81.
11. 6 serotonin receptor. J. Neurochem., 1996, 66, 47-56. (Pubitemid 26010763)
12. Monsma, F. J.; Shen, Y.; Ward, R. P., et al. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol, 1993, 43, 320-7. (Pubitemid 23081986)
13. 6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biiochem. Biophys. Res. Commmun., 1993, 193, 268-76. (Pubitemid 23199942)
14. 7) activating cAMP formation. Proc. Natl. Acad. Sci. USA, 1993, 90, 8547-51. (Pubitemid 23277706)
15. 7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with Tourette syndrome. Genomics, 1995, 26, 207-9.
16. 7 receptors in guinea pig brain. Br. J. Pharmacol., 1995, 115, 107-16.
17. 7A receptor. J. Biol. Chem., 1998, 273, 17469-76. (Pubitemid 28355078)
18. Shen, W. Z.; Luo, Z. B.; Zheng, D. R.; Yew, D. T. Immunohistochemical studies on the development of 5-HT (serotonin) neurons in the nuclei of the reticular formations of human fetuses. Pediatr. Neurosci., 1989, 15(6), 291-5.
19. Lorke, D. E.; Lu, G.; Cho, E.; Yew, D. T. Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients. BMC Neurosc., 2006, 7, 36.
20. Loyd, D. R.; Weiss, G.; Henry, M. A.; Hargreaves, K. M. Serotonin increases the functional activity of capsaicin-sensitive rat trigeminal nociceptors via peripheral serotonin receptors. Pain, [Online] 2011.
21. Bonnavion, P.; Bernard, J. F.; Hamon, M.; Adrien, J.; Fabre, V. Heterogeneous distribution of the serotonin 5-HT (1A) receptor mRNA in chemically identified neurons of the mouse rostral brainstem: Implications for the role of serotonin in the regulation of wakefulness and REM sleep. J. Comp. Neurol., 2010, 518(14), 2744-70.
22. 2A positive cells in the brainstems of control age-matched and Alzheimer individuals. Age (Dordr), 2010, 32(4), 483-95.
23. Vitalis, T, Parnavelas, J. G. The role of serotonin in early cortical development. Dev. Neurosci., 2003, 25(2-4), 245-56. (Pubitemid 37100217)
24. Wai M. S., Shi C., Kwong W. H., Zhang L., Lam W. P., Yew D. T. Development of the human insular cortex: differentiation, proliferation, cell death, and appearance of 5-HT-2A receptors. Histochem. Cell Biol., 2008, 130(6), 1199-204.
25. Wai, M. S.; Lorke, D. E.; Kwong, W. H.; Zhang, L.; Yew, D. T. Profiles of serotonin receptors in the developing human thalamus. Psychiatry Res., 2011, 185(1-2), 238-42.
26. Brodal, A. Neurological anatomy in relation to clinical medicine; Oxford University Press: New York, 1981.
27. Heidbreder, C. A.; Oertle, T.; Feldon, J. Dopamine and serotonin imbalances in the left anterior cingulate and pyriform cortices following the repeated intermittent administration of cocaine. Neuroscience. 1999, 89(3), 701-15. (Pubitemid 29070997)
28. Perrotti, L. I.; Beck, K. D.; Luine, V. N.; Quiñones, V. Progesterone and cocaine administration affect serotonin in the medial prefrontal cortex of ovariectomized rats. Neurosci. Lett., 2000, 291(3), 155-8. (Pubitemid 30657915)
29. 2A receptor positive cells in the cerebella of mice and human and their decline during aging. Miicrosc. Res. Tech., 2009, 72(9), 684-9.
30. Cheetham, S. C.; Crompton, M. R.; Katona, C. L.; Horton, R. W. Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology (Berl), 1990, 102(4), 544-8. (Pubitemid 20379512)
31. Meltzer H. Y. Serotonin receptors and antipsychotic drug action. Psychopharmacol Ser., 1993, 10, 70-81.
32. Bose, S. K.; Mehta, M. A.; Selvaraj, S.; Howes, O. D.; Hinz, R.; Rabiner, E. A.; Grasby, P. M.; Turkheimer, F. E.; Murthy, V. Presynaptic 5-HT1A is Related to 5-HTT Receptor Density in the Human Brain. Neuropsychopharmacology, [Online] 2011.
33. Murphy, D. L.; Zohar, J.; Benkelfat, C.; Pato, M. T.; Pigott, T. A.; Insel, T. R. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder. Br J. Psychiatry Suppl., 1989, (8), 15-24.
34. Berendsen, H. H. Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans? Pharmacol. Ther., 1995, (66), 17-37.
35. Lieberman, J. A.; Mailman, R. B.; Duncan, G.; Sikich, L.; Chakos, M.; Nichols, D. E.; Kraus J. E. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol. Ps ychiatry, 1998, 44(11), 1099-117. (Pubitemid 28547145)
36. Pandey, G. N.; Dwivedi, Y.; Ren, X.; Rizavi, H. S.; Faludi, G.; Sarosi A.; Palkovits M. Regional distribution and relative abundance of serotonin (2c) receptors in human brain: effect of suicide. Neurochem. Res., [Online] 2006, 31(2), 167-76.
37. Stahl, S. 5HT1A receptors and pharmacotherapy. Is serotonin receptor downregulation linked to the mechanism of action of antidepressant drugs? Psychopharmacology Bull., 1994, 30(1), 39-43. (Pubitemid 24258746)
38. Thakur, M. K., Prasad, S. Eds. Cellular and Molecular Neurobiology; Narosa Publishing House: New Delhi, India, 2005; Section B
39. Eison, A. S.; Eison, M. S. Serotonergic mechanisms in anxiety. Prog. Neuropsychopharmacol Biol. Psychiatry., 1994, 18(1), 47-62.
40. 1A receptors. Psychopharmacology, 1987, 91(1), 25-9. (Pubitemid 17000883)
41. 3H imipramine binding. Ciba Found. Symp., 1986, 123, 57-83.
42. Subhash M. N., Srinivas B. N., Vinod K. Y. Alterations in 5-HT (1A) receptors and adenylyl cyclase response by trazodone in regions of rat brain. Life Sci., 2002, 71(13), 1559-67. (Pubitemid 34804587)
43. Subhash M. N.; Srinivas B. N.; Vinod K. Y.; Jagadeesh S. Modulation of 5-HT1A receptor mediated response by fluoxetine in rat brain. J. Neural. Transm., 2000, 107(3), 377-87. (Pubitemid 30162699)
44. Sheldon, P. W.; Aghajanian, G. K. Serotonin (5-HT) induces IPSPs in pyramidal layer cells of rat piriform cortex: evidence for the involvement of a 5-HT2-activated interneuron. Brain Res, 1990, 506(1), 62-9. (Pubitemid 20020075)
45. Pettersson, M.; Campbell, B. M.; Dounay, A. B.; Gray, D. L.; Xie, L.; O'Donnell, C. J.; Stratman, N. C.; Zoski, K.; Drummond, E.; Bora, G.; Probert, A.; Whisman, T. Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT (1A) partial agonists. Bioorg. Med. Chem. Lett., [Online] 2011, 21(2), 865-8.
46. Bang-Andersen, B.; Ruhland, T.; Jørgensen, M.; Smith, G.; Frederiksen, K.; Jensen, K. G.; Zhong, H.; Nielsen, S. M.; Hogg, S.; Mørk, A.; Stensbøl, T. B.; Discovery of 1-[2-(2, 4-dimethylphenylsulfanyl) phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J. Med. Chem., [Online] 2011, 54(9), 3206-21.
47. Fétique-Will, A. C.; Chevalley, T.; Rizzoli, R. Selective serotonin reuptake inhibitors (SSRI) and osteoporosis. Rev. Med. Suisse, 2011, 7(299), 1299-304.
48. Goldman-Rakic, P. S.; Lidow, M. S.; Gallager, D. W. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. J. Neurosci., 1990, 10(7), 2125-38.
49. Jakab, R. L.; Goldman-Rakic, P. S. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Prroc. Natl. Acad. Sci. U S A, 1998, 95(2), 735-40.
50. Santana, N.; Bortolozzi, A.; Serrats, J.; Mengod, G.; Artigas, F. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb. Cortex, 2004, 14(10), 1100-9. (Pubitemid 39258165)
51. Bonaventure, P.; Voorn, P.; Luyten, W. H.; Leysen, J. E.; 5HT1B and 5HT1D receptor mRNA differential co-localization with peptide mRNA in the guinea pig trigeminal ganglion. Neuroreport, 1998, 9(4), 641-5. (Pubitemid 28131278)
52. Hou, M.; Kanje, M.; Longmore, J.; Tajti, J.; Uddman, R.; Edvinsson, L. 5-HT (1B) and 5-HT (1D) receptors in the human trigeminal ganglion: colocalization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brrain Res., 2001, 909(1-2), 112-20. (Pubitemid 32710124)
53. Puig, M. V.; Celada, P.; Artigas, F. [Serotonergic control of prefrontal cortex] [Article in Spanish]. Rev. Neurol., 2004, 39(6), 539-47. (Pubitemid 39472013)
54. Tournois, C.; Mutel, V.; Manivet, P.; Launay, J. M.; Kellermann, O. Crosstalk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolism. J. Biol. Chem., 1998, 273(28), 17498-503. (Pubitemid 28355082)
55. Summavielle, T.; Alves, C. J.; Monteiro, P. R.; Tavares, M. A. Abnormal immunoreactivity to serotonin in cerebellar Purkinje cells after neonatal cocaine exposure. Ann. N Y Acad. Sci., 2004, 1025, 630-7. (Pubitemid 39643917)
56. Henderson, M. G.; McMillen, B. A. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs. Teratology, 1993, 48(5), 421-30. (Pubitemid 24002098)
57. Baumann, M. H.; Rothman, R. B. Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans. Biol. Psychiatry, 1998, 44(7), 578-91. (Pubitemid 28496685)
58. * pattern cocaine administration. Syynapse, 1998, 30(2), 166-71. (Pubitemid 28376375)
59. Lehto, S. M.; Tolmunen, T.; Joensuu, M.; Saarinen, P. I.; Valkonen-Korhonen, M.; Vanninen, R.; Ahola, P.; Tiihonen, J.; Kuikka, J.; Lehtonen, J. Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy. Prog. Neuropsychopharmacol Biol. Psychiatry, 2008, 32(1), 229-37.
60. Humblot, N.; Thiriet, N.; Gobaille, S.; Aunis, D.; Zwiller, J. The serotonergic system modulates the cocaine-induced expression of the immediate early genes egr-1 and c-fos in rat brain. Ann. N Y Acad. Sci., 1998, 844, 7-20. (Pubitemid 28367791)
61. Belej T, Manji D, Sioutis S, Barros HM, Nobrega JN. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre-vs. postwithdrawal effects. Brain Res., 1996, 736(1-2), 287-96. (Pubitemid 26356487)
62. Dworkin, S. I.; Co, C.; Smith, J. E. Rat brain neurotransmitter turnover rates altered during withdrawal from chronic cocaine administration. Brain Res., 1995, 682(1-2), 116-26.
63. Carey, R. J.; Damianopoulos, E. N. Conditioned cocaine induced hyperactivity: an association with increased medial prefrontal cortex serotonin. Behav. Brain Res, 1994, 62(2), 177-85. (Pubitemid 24222826)
64. Kish, S. J.; Lerch, J.; Furukawa, Y.; Tong, J.; McCluskey, T.; Wilkins, D.; Houle, S.; Meyer, J, Mundo, E.; Wilson, A. A.; Rusjan, P. M.; Saint-Cyr, J. A.; Guttman, M.; Collins, D. L.; Shapiro, C.; Warsh, J. J.; Boileau, I. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11) C]DASB and structural brain imaging study. Brain, 2010, 133(Pt 6), 1779-97.
65. Ghitza, U. E.; Rothman, R. B.; Gorelick, D. A.; Henningfield, J. E.; Baumann M. H. Serotonergic responsiveness in human cocaine users. Drug Alcohol Depend., 2007, 86(2-3), 207-13. (Pubitemid 44830096)
66. Zitterl, W.; Aigner, M.; Stompe, T.; Zitterl-Eglseer, K.; Gutierrez-Lobos, K.; Wenzel, T.; Zettinig, G.; Hornik, K.; Pirker, W.; Thau, K. Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder. Neuropsychopharmacology, 2008, 33(13), 3126-34.
67. Buydens-Branchey, L.; Branchey, M.; Hudson, J.; Rothman, M.; Fergeson, P.; McKernin, C. Serotonergic function in cocaine addicts: prolactin responses to sequential D, L-fenfluramine challenges. Biol. Psychiatry, 1999, 45(10), 1300-6. (Pubitemid 29292506)
68. Chan W. Y.; Xia C. L.; Dong D. C.; Heizmann C. W.; Yew D. T. Differential expression of S100 proteins in the developing human hippocampus and temporal cortex. Microsc. Res. Tech., 2003, 60(6), 600-13.
69. Fang M.; Lorke D. E.; Li J.; Gong X.; Yew J. C.; Yew D. T. Postnatal changes in functional activities of the pig's brain: a combined functional magnetic resonance imaging and immunohistochemical study. Neurosignals., 2005, 14(5), 222-33. (Pubitemid 41661356)
70. Jen P. Y.; Li W. W.; Yew D. T. Immunohistochemical localization of neuropeptide Y and somatostatin in human fetal retina. Neuroscience, 1994, 60(3), 727-35. (Pubitemid 24163920)
71. Kwong W. H.; Chan W. Y.; Lee K. K.; Fan M.; Yew D. T. Neurotransmitters, neuropeptides and calcium binding proteins in developing human cerebellum: a review. Histochem. J., 2000, 32(9), 521-34.
72. Lorke D. E.; Kwong W. H.; Chan W. Y.; Yew D. T. Development of catecholaminergic neurons in the human medulla oblongata. Life Sci., 2003, 73(10), 1315-31. (Pubitemid 36794595)
73. Luo C. B.; Yew D. T.; Zheng D. R.; Liu Y. Q. Acetylcholinesterase- containing neurons, substance P and enkephalin fibers in the ventral horns of developing human embryos and fetuses. Neuroscience, 1992, 48(4), 979-84.
74. Luo C. B.; Zheng D. R.; Guan Y. L.; Shen W. Z.; Liu Y. G.; Ye w D. T. Localization of acetylcholinesterase positive neurons and substance P and enkephalin positive fibers by histochemistry and immunohistochemistry in the sympathetic intermediate zone of the developing human spinal cord. Neuroscience, 1990, 39(1), 97-102.
75. Luo C. B.; Zheng D. R.; Guan Y. L.; Yew D. T. Localization of substance P and enkephalin by immunohistochemistry in the spinal cord of human fetus. Neuroscience, 1988, (3), 989-93. (Pubitemid 19025406)
76. Shen W. Z.; Luo C. B.; Dong L.; Chan W. Y.; Yew D. T. Distribution of neuropeptide Y in the developing human spinal cord. Neuroscience, 1994, 62(1), 251-6. (Pubitemid 24287359)
77. Shen W. Z.; Luo Z. B.; Zheng D. R.; Yew D. T. Immunohistochemical studies on the development of 5-HT (serotonin) neurons in the nuclei of the reticular formations of human fetuses. Pediatr. Neurosci., 1989, 15(6), 291-5.
78. Tiu S. C.; Chan W. Y.; Heizmann C. W.; Schafer B. W.; Shu S. Y.; Yew D. T. Erratum to: differential expression of S100B (1) and S100A6 (1) in the human fetal and aged cerebral cortex. Brain Res Dev Brain Res., 2000, 124(1-2), 153.
79. Tiu S. C.; Chan W. Y.; Heizmann C. W.; Schäfer B. W.; Shu S. Y.; Yew D. T. Differential expression of S100B and S100A6 (1) in the human fetal and aged cerebral cortex. Brain Res. Dev. Brain Res., 2000, 119(2), 159-68. (Pubitemid 30089806)
80. Tiu S. C.; Yew D. T.; Chan W. Y. Development of the human cerebral cortex: a histochemical study. Prog. Histochem. Cytochem., 2003, 38(1), 3-149.
81. Wai S. M.; Kindler P. M.; Lam E. T.; Zhang A.; Yew D. T. Distribution of neuropeptide Y-immunoreactive neurons in the human brainstem, cerebellum, and cortex during development. Cell Mol. Neurobiol., 2004, 24(5), 667-84. (Pubitemid 39062429)
82. Wu S.; Zhu M.; Wang W.; Wang Y.; Li Y.; Yew D. T. Changes of the expression of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by complete Freund's adjuvant-induced inflammation. Neurosc.i Lett., 2001, 307(3), 183-6. (Pubitemid 32595659)
83. Yew D. T.; Chan W. Y. Early appearance of acetylcholinergic, serotoninergic, and peptidergic neurons and fibers in the developing human central nervous system. Microsc. Res. Tech., 1999, 45(6), 389-400. (Pubitemid 29321053)
84. Yew D. T.; Li W. P.; Webb S. E.; Lai H. W.; Zhang L. Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients: a comparison. Exp. Gerontol., 1999, 34(1), 117-33. (Pubitemid 29085073)
85. Yew D. T.; Luo C. B.; Heizmann C. W.; Chan W. Y. Differential expression of calretinin, calbindin D28K and parvalbumin in the developing human cerebellum. Brain Res. Dev. Brain Res., 1997, 103(1), 37-45. (Pubitemid 27465708)
86. Yew D. T.; Luo C. B.; Luo J. M.; Kwong W. H.; Chan W. Y. Substance P and enkephalin containing fibers in the developing nucleus dorsalis of the human spinal cord. Neurosci. Lett., 2001, 312(2), 87-90. (Pubitemid 32938235)
87. Yew D. T.; Luo C. B.; Shen W. Z.; Chow P. H.; Zheng D. R.; Yu M. C. Tyrosine hydroxylase-and dopamine-beta-hydroxylase-positive neurons and fibres in the developing human cerebellum-an immunohistochemical study. Neuroscience., 1995, 65(2), 453-61.
88. Yew D. T.; Luo C. B.; Zheng D. R.; Guan Y. L.; Lin Y. Q.; Chen W. Z. Development and localization of enkephalin and substance P in the nucleus of tractus solitarius in the medulla oblongata of human fetuses. Neuroscience, 1990, 34(2), 491-8. (Pubitemid 20110153)
89. Yew D. T.; Luo C. B.; Zheng D. R.; Guan Y. L.; Tsang D.; Stadlin A. Immunohistochemical localization of substance P, enkephalin and serotonin in the developing human retina. J Hirnforsch., 1991, 32(1), 61-7.
90. Yew D. T.; Pang K. M.; Mok Y. C. Immunohistochemical and ultrastructural studies of the various nuclei of the trigeminal complex in the human newborn. Neuroscience., 1991, 45(1), 23-35.
91. Yew D. T.; Webb S. E.; Lam E. T. Neurotransmitters and peptides in the developing human facial nucleus. Neurosci. Lett., 1996, 206(1), 65-8. (Pubitemid 26084730)
92. Yu M. C.; Cho E.; Luo C. B.; Li W. W.; Shen W. Z.; Yew D. T. Immunohistochemical studies of GABA and parvalbumin in the developing human cerebellum. Neuroscience, 1996, 70(1), 267-76. (Pubitemid 126755241)
93. Yu M. C.; Luo C. B.; Long L.; Yew D. T. An immunohistochemical study of neuropeptide Y positive sites in the developing human hippocampal formation. Brain Res. Dev. Brain Res., 1993, 72(2), 277-81. (Pubitemid 23116175)
94. Li, Q.; Lu, G.; Antonio, G. E.; Mak, Y. T.; Rudd, J. A.; Fan, M.; Yew, D. T. The usefulness of the spontaneously hypertensive rat to model attentiondeficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain. Neurochem. Int., 2007, 50(6), 848-57. (Pubitemid 46722647)
95. Fang M.; Li J.; Tiu S. C.; Zhang L.; Wang M.; Yew D. T. N-methyl-D-aspartate receptor and apoptosis in Alzheimer's disease and multiinfarct dementia. J. Neurosci. Res., 2005, 81(2), 269-74. (Pubitemid 41153341)
96. Li W. P.; Lai H. W.; Cheng S. Y.; Yew D. T. Somatostatin-positive neurons in the different parts of the brain in normal aging and Alzheimer's disease. Biol. Signals., 1996, 5(6), 343-8. (Pubitemid 27064958)
97. Yew D. T.; Wong H. W.; Li W. P.; Lai H. W.; Yu W. H. Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains. Neuroscience, 1999, 89(3), 675-86. (Pubitemid 29070995)
98. Lambe, E. K.; Fillman, S. G.; Webster, M. J.; Shannon, W. C. Serotonin Receptor Expression in Human Prefrontal Cortex: Balancing Excitation and Inhibition across Postnatal Development. PLoS One, 2011, 6(7):e22799.